期刊文献+

P73、c-Abl蛋白在卵巢肿瘤组织中的表达及临床意义

Expression of P73 and c-Abl proteins in ovarian carcinomas and its clinical significance
下载PDF
导出
摘要 目的研究P73、c-Abl蛋白在卵巢肿瘤组织中的表达情况及相互关系,探讨其在卵巢肿瘤发生、发展中的作用。方法应用免疫组化SP法检测61例卵巢恶性肿瘤、28例卵巢交界性肿瘤和30例卵巢良性肿瘤组织中P73、c-Abl蛋白的表达情况。结果P73蛋白在卵巢良性、交界性、恶性肿瘤组织中的表达呈逐渐增高趋势;卵巢恶性肿瘤内P73蛋白的表达与组织分化有关,在低分化癌中有较高表达;卵巢癌患者中P73蛋白阴性表达者的生存期明显长于阳性表达者;c-Abl蛋白在卵巢良性、交界性、恶性肿瘤组织中的表达有显著差异(P<0.01),在卵巢癌中呈高表达;P73蛋白和c-Abl蛋白在卵巢癌中呈正相关性高表达(P<0.01)。结论p73基因以高表达方式参与卵巢癌的发生发展过程,卵巢癌中P73蛋白的高表达与c-Abl蛋白的高表达有关。P73蛋白的表达强度能够反映卵巢癌的恶性程度,可作为判断肿瘤生物学行为的参数和卵巢癌预后的指标。 Objective To investigate the expressions of P73 and c-Abl in ovarian tumors and the relationship of the expressions with the development of ovarian tumors. Methods The expressions of P73 and c-Abl proteins in 61 cases of malignant ovarian tumor,28 cases of borderline ovarian tumor and 30 cases of benign ovarian cancer was analyzed with immunohistochemisty technique. Results There were obvious differences of P73 expression among the three groups (P 〈 0.01 ), the expression were gradually higher in order of benign ovarian tumor, borderline ovarian tumor and malignant ovarian tumor. The expression of P73 was correlated with the differentiation of malignant ovarian tumor and it had higher expression in cases of lower differentiation ( P 〈 0.05 ). As P73 being negative, the survival time of patients were much longer (P 〈 0.01 ). Expressions of c-Abl were obvious different among benign ovarian tumor, borderline ovarian tumor and malignant ovarian tumor ( P 〈 0.01 ) , and high in ovarian cancer. P73 expression had positive correlation with e-Abl expression (P 〈 0.01 ). Conclusion p73 gene is involved in the development of ovarian cancer, the over expression of P73 is related with the expression of c-Abl. The intensity of P73 expression represents the grade of ovarian cancer,it is an important parameter for estimating biological behavior of tumor and a predictable factor in diagnosing ovarian cancer.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2008年第6期629-633,共5页 Journal of Harbin Medical University
关键词 卵巢肿瘤 P73 c—Abl 免疫组织化学 ovarian tumor P73 c-Abl immunohistochemistry
  • 相关文献

参考文献13

  • 1Toh WH,Siddique MM, Boominathan L, et al. c-Jun regulates the stability and activity of the p53 homologue,P73[ J]. J Biol Chem, 2004,22(43) :44713-44722.
  • 2Taagepera S, McDonald D, Loeb JE, et al. NuClear-cytoplasmic shuttling of C-ABL tyrosine kinase [ J ]. Proc Natl Acad Sci U S A,1998,23(13) :7457-7462.
  • 3Sanchez-Prieto R, Sanchez-Arevalo VJ, Servitja JM, et al. Regulation of P73 by c-Abl through the p38 MAP kinase pathway[ J]. Oncogene,2002,31 ( 6 ) : 974-979.
  • 4Romani M ,Tonini GP, Banelli B ,et al. Biological and clinical role of P73 in neuroblastoma [ J]. Cancer Lett,2003,18 (1-2) : 111- 117.
  • 5Stiewe T, Zimmermann S, Frilling A,et al. Transactivation-deficient DeltaTA-P73 acts as an oncogene [ J ]. Cancer Res,2002,11 ( 13 ) : 3598-3602.
  • 6Grob TJ, Novak U, Maisse C, et al. Human delta NP73 regulates a dominant negative feedback loop for TAP73 and p53 [ J ]. Cell Death Differ,2001,8(12) :1213-1223.
  • 7Imyanitov EN, Birrell GW, Filippovich I ,et al. Frequent loss of heterozygosity at 1 p36 in ovarian adenocarcinomas but the gene encoding P73 is unlikely to be the target [ J ]. Oncogene, 1999, 12 (32) :4640-4642.
  • 8Mai M, Yokomizo A, Qian C,et al. Activation of P73 silent allele in lung cancer[ J]. Cancer Res, 1998,58 ( 11 ) :2347-2349.
  • 9Ng SW,Gary KY, Yan Lm,et al. Analysis of P73 in human borderline and invasive ovarian tumor[ J]. Oncogene,2000,19 (15) : 1885-1890.
  • 10Zwahlen D, Tschan MP, Grob TJ, et al. Differential expression of P73 splice variants and protein in benign and malignant ovarian tumours[ J]. Int J Cancer,2000,1 ( 1 ) :66-70.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部